Follow
Jeremy Squire
Jeremy Squire
Departmento de Genética, Faculdade de Medicina de Ribeirão Preto, University of Sao Paulo
Verified email at fmrp.usp.br - Homepage
Title
Cited by
Cited by
Year
Identification of human brain tumour initiating cells
SK Singh, C Hawkins, ID Clarke, JA Squire, J Bayani, T Hide, ...
nature 432 (7015), 396-401, 2004
91972004
Identification of a cancer stem cell in human brain tumors
SK Singh, ID Clarke, M Terasaki, VE Bonn, C Hawkins, J Squire, PB Dirks
Cancer research 63 (18), 5821-5828, 2003
68742003
Erlotinib in lung cancer—molecular and clinical predictors of outcome
MS Tsao, A Sakurada, JC Cutz, CQ Zhu, S Kamel-Reid, J Squire, ...
New England Journal of Medicine 353 (2), 133-144, 2005
23002005
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists …
NI Lindeman, PT Cagle, MB Beasley, DA Chitale, S Dacic, G Giaccone, ...
Journal of Thoracic Oncology 8 (7), 823-859, 2013
19282013
Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens
SM Pollard, K Yoshikawa, ID Clarke, D Danovi, S Stricker, R Russell, ...
Cell stem cell 4 (6), 568-580, 2009
11412009
Mutations in SUFU predispose to medulloblastoma
MD Taylor, L Liu, C Raffel, C Hui, TG Mainprize, X Zhang, R Agatep, ...
Nature genetics 31 (3), 306-310, 2002
9832002
Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
CQ Zhu, G da Cunha Santos, K Ding, A Sakurada, JC Cutz, N Liu, ...
Journal of clinical oncology 26 (26), 4268-4275, 2008
8662008
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer
D Lechardeur, KJ Sohn, M Haardt, PB Joshi, M Monck, RW Graham, ...
Gene therapy 6 (4), 482-497, 1999
7971999
High-resolution mapping of mammalian genes by in situ hybridization to free chromatin.
HH Heng, J Squire, LC Tsui
Proceedings of the National Academy of Sciences 89 (20), 9509-9513, 1992
6901992
Clinical implications of PTEN loss in prostate cancer
T Jamaspishvili, DM Berman, AE Ross, HI Scher, AM De Marzo, JA Squire, ...
Nature Reviews Urology 15 (4), 222-234, 2018
5482018
Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome
R Weksberg, D Ren Shen, Y Ling Fei, Q Li Song, J Squire
Nature genetics 5 (2), 143-150, 1993
5201993
TAp73 knockout shows genomic instability with infertility and tumor suppressor functions
R Tomasini, K Tsuchihara, M Wilhelm, M Fujitani, A Rufini, CC Cheung, ...
Genes & development 22 (19), 2677-2691, 2008
5122008
Genetic origin of mutations predisposing to retinoblastoma
WK Cavenee, MF Hansen, M Nordenskjold, E Kock, I Maumenee, ...
Science 228 (4698), 501-503, 1985
5101985
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
AM Haslehurst, M Koti, M Dharsee, P Nuin, K Evans, J Geraci, T Childs, ...
BMC cancer 12, 1-10, 2012
4442012
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
M Meyer, J Reimand, X Lan, R Head, X Zhu, M Kushida, J Bayani, ...
Proceedings of the National Academy of Sciences 112 (3), 851-856, 2015
4132015
Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith–Wiedemann syndrome
R Weksberg, C Shuman, O Caluseriu, AC Smith, YL Fei, J Nishikawa, ...
Human Molecular Genetics 11 (11), 1317-1325, 2002
3892002
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
3762014
Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype
H Ouyang, L Mou, C Luk, N Liu, J Karaskova, J Squire, MS Tsao
The American journal of pathology 157 (5), 1623-1631, 2000
3672000
Cause and consequences of genetic and epigenetic alterations in human cancer
B Sadikovic, K Al-Romaih, JA Squire, M Zielenska
Current genomics 9 (6), 394-408, 2008
3642008
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M Yoshimoto, IW Cunha, RA Coudry, FP Fonseca, CH Torres, FA Soares, ...
British journal of cancer 97 (5), 678-685, 2007
3622007
The system can't perform the operation now. Try again later.
Articles 1–20